Canadian Pharmacy Conspiracy Charges

28 May 1995

In Quebec, Canada, the province's pharmacy owners association and six leading drugstore chains have been convicted of conspiracy and now face fines totalling C$2 million.

The conviction came after the pharmacists pleaded guilty to fixing the prices of oral contraceptives and prescription narcotic products. In return for the guilty plea, the Quebec Superior Court has dropped conspiracy charges against seven managers of the association and the drugstore chains.

The Crown investigation into the price-fixing began in 1988, when a woman complained that the price of her contraceptives had gone up more than 16.5% in a month. A case was brought against the association and 17 pharmacies in April 1990, but in December of that year a Quebec Superior Court ruled that the section of Canada's Competition Act dealing with conspiracy constituted a violation of the federal Charter of Rights and Freedoms' guarantees of liberty.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight